METHOD OF TREATING EXUDATIVE OTITIS MEDIA IN CHILDREN Russian patent published in 2011 - IPC A61K38/21 A61P27/16 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, in particular to otolaryngology, and can be used for treatment of exudative otitis media. Method includes shunting of tympanic cavity with hollow prosthesis, introduction to patients in post-operation period of antibacterial medication of wide spectrum of action, mucolytic medication, endaural introduction of proteolytic medication, vasoconstrictive drops into nose. Additionally simultaneously, perorally introduced is preparation "Reaferon-EC-Lipint" in dose: children of 3-15 years 125000 IU daily 2 times per day for 7 days, children from 16-18 years - 250000 IU daily 2 times per day for 7 days. From eighth to tenth day of treatment patients continue to obtain peroral introduction of Reaferon-EC-Lipint in the following dose: children of 3-15 years 250000 IU daily 2 times per day for 3 days, children from 16-18 years -500000 IU daily 2 times per day for 3 days.

EFFECT: method makes it possible to increase efficiency of treatment of exudative otitis media in children and reduce number of disease recurrences.

1 tbl, 2 ex